PMID- 22586056 OWN - NLM STAT- MEDLINE DCOM- 20120712 LR - 20230718 IS - 1943-7722 (Electronic) IS - 0002-9173 (Linking) VI - 137 IP - 6 DP - 2012 Jun TI - Solitary fibrous tumor: is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? PG - 963-70 LID - 10.1309/AJCPQEG6YNN6CNAL [doi] AB - Solitary fibrous tumor (SFT) is a mesenchymal tumor characterized by ovoid cells, branching blood vessels, stromal hyalinization, and CD34 immunoreactivity. Studies have shown loss of 13q in a group of morphologically similar entities, including cellular angiofibroma, mammary-type myofibroblastoma, and spindle cell lipoma. The histologic and immunophenotypic overlap between SFT and the latter group of tumors suggests that these tumors may be genetically linked. We tested a group of 40 SFTs to assess for loss of RB1 (13q14) by fluorescence in situ hybridization (FISH). All 38 SFTs with evaluable signals failed to show loss of RB1 (13q14) by FISH. All cases of cellular angiofibroma (1/1), spindle cell lipoma (6/6), and mammary-type myofibroblastoma (4/4), which were used as a control group, showed monoallelic or biallelic loss of RB1. The absence of RB1 loss in SFTs suggests that they are not related to cellular angiofibroma, mammary-type myofibroblastoma, or spindle cell lipoma. FAU - Fritchie, Karen J AU - Fritchie KJ AD - Departments of L aboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. FAU - Carver, Paula AU - Carver P FAU - Sun, Yang AU - Sun Y FAU - Batiouchko, Galina AU - Batiouchko G FAU - Billings, Steven D AU - Billings SD FAU - Rubin, Brian P AU - Rubin BP FAU - Tubbs, Raymond R AU - Tubbs RR FAU - Goldblum, John R AU - Goldblum JR LA - eng PT - Journal Article PL - England TA - Am J Clin Pathol JT - American journal of clinical pathology JID - 0370470 RN - 0 (Antigens, CD34) RN - 0 (Biomarkers, Tumor) RN - 0 (Retinoblastoma Protein) SB - IM MH - Adult MH - Aged MH - Angiofibroma/genetics/pathology MH - Antigens, CD34/immunology MH - Biomarkers, Tumor/*genetics MH - Breast/pathology MH - Female MH - Follow-Up Studies MH - Humans MH - Immunophenotyping MH - In Situ Hybridization, Fluorescence MH - Lipoma/genetics/pathology MH - Male MH - Middle Aged MH - Neoplasms, Muscle Tissue/genetics/pathology MH - Retinoblastoma Protein/*genetics MH - Solitary Fibrous Tumors/*diagnosis/*genetics/pathology EDAT- 2012/05/16 06:00 MHDA- 2012/07/13 06:00 CRDT- 2012/05/16 06:00 PHST- 2012/05/16 06:00 [entrez] PHST- 2012/05/16 06:00 [pubmed] PHST- 2012/07/13 06:00 [medline] AID - 137/6/963 [pii] AID - 10.1309/AJCPQEG6YNN6CNAL [doi] PST - ppublish SO - Am J Clin Pathol. 2012 Jun;137(6):963-70. doi: 10.1309/AJCPQEG6YNN6CNAL.